Form 4: Omada Health President Executes Stock Sale

President Wei-Li Shao sold 4,589 shares of Omada Health common stock via a pre-arranged 10b5-1 trading plan.

Summary

• Wei-Li Shao, President of Omada Health, sold 4,589 shares of common stock on June 12, 2026.
• The shares were sold at a weighted average price of $17.2407 per share.
• Following the transaction, the reporting person retains beneficial ownership of 316,238 shares.
• The sale was conducted under a Rule 10b5-1 trading plan adopted on March 13, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was conducted through a pre-planned, automated mechanism.

Positives

• The transaction was executed under a pre-established 10b5-1 plan, indicating the sale was not based on sudden material non-public information.

Negatives

• The sale represents a reduction in the insider's direct equity stake in the company.

Risks

• Insider selling can sometimes be perceived negatively by the market as a signal of management's view on current valuation.

Future Outlook

No specific forward-looking guidance regarding company performance was provided in this filing.

Industry Context

StockSavvy.ai notes that routine insider selling under 10b5-1 plans is a standard corporate governance practice and typically does not reflect a change in the company's fundamental outlook.

Comparison to Industry Standards

• The use of 10b5-1 plans is the industry standard for executives to liquidate equity positions while avoiding potential insider trading liability.

Stakeholder Impact

• Minimal impact on shareholders as the sale was pre-planned and represents a small fraction of the executive's total holdings.

Next Steps

• No further actions required by the reporting person regarding this specific transaction.

Key Dates

Keywords

Omada Health, Insider Trading, Form 4, Wei-Li Shao, Stock Sale, 10b5-1